HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (58) Citing Articles via Google Scholar Google Scholar Articles by Melmed, S Articles by Giustina, A Search for Related Content PubMed PubMed Citation Articles by Melmed, S Articles by Giustina, A

Consensus statement: medical management of acromegaly

Cedar-Sinai Research Institute, UCLA School of Medicine, Los Angeles, USA, ¹ Santiago de Compostela University, Spain, ² University of Milan, Italy, ³ Hospital Bicetre; Paris, France, ⁴ University of Illinois, Chicago, USA, ⁵ University Hospital CHUV, Lausanne, Switzerland, ⁶ University of Turin, Italy, ⁷ Garvan Institute of Medical Research, Australia, ⁸ Universitè de la Mediterraneè, Marseille, France, ⁹ NY University Medical Center, New York, USA, ¹⁰ University Hospital, Rotterdam, the Netherlands, ¹¹ University of Virginia, Charlottesville, USA, ¹² School of Medicine, Naples, Italy, ¹³ University of Birmingham, UK, ¹⁴ Radcliffe Infirmary, Oxford, UK and ¹⁵ University of Brescia, c/o 2° Medicina, Spedali Civili, Brescia 25125, Italy

(Correspondence should be addressed to A Giustina; Email: a.giustina{at}libero.it)

Abstract

In November 2003, the Pituitary Society and the European Neuroendocrine Association sponsored a consensus workshop in Seville to address challenging issues in the medical management of acromegaly. Participants comprised 70 endocrinologists and neurosurgeons with international expertise in managing patients with acromegaly. All participants participated in the workshop proceedings, and the final document written by the scientific committee reflects the consensus opinion of the interactive deliberations. The meeting was supported by an unrestricted educational grant from Ipsen. No pharmaceutical representatives participated in the program planning or in the scientific deliberations.

This article has been cited by other articles:

				M Buchfelder, D Weigel, M Droste, K Mann, B Saller, K Brubach, G K Stalla, M Bidlingmaier, C J Strasburger, and on behalf of the investigators of the German Pegvi Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study Eur. J. Endocrinol., July 1, 2009; 161(1): 27 - 35. [Abstract] [Full Text] [PDF]

				A. Bianchi, A. Giustina, V. Cimino, R. Pola, F. Angelini, A. Pontecorvi, and L. De Marinis Influence of Growth Hormone Receptor d3 and Full-Length Isoforms on Biochemical Treatment Outcomes in Acromegaly J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2015 - 2022. [Abstract] [Full Text] [PDF]

				G. Mazziotti, I. Floriani, S. Bonadonna, V. Torri, P. Chanson, and A. Giustina Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1500 - 1508. [Abstract] [Full Text] [PDF]

				S. Melmed, A. Colao, A. Barkan, M. Molitch, A. B. Grossman, D. Kleinberg, D. Clemmons, P. Chanson, E. Laws, J. Schlechte, et al. Guidelines for Acromegaly Management: An Update J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1509 - 1517. [Abstract] [Full Text] [PDF]

				N. Moller and J. O. L. Jorgensen Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects Endocr. Rev., April 1, 2009; 30(2): 152 - 177. [Abstract] [Full Text] [PDF]

				J. D. Carmichael, V. S. Bonert, J. M. Mirocha, and S. Melmed The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 523 - 527. [Abstract] [Full Text] [PDF]

				G. Mazziotti, A. Bianchi, S. Bonadonna, V. Cimino, I. Patelli, A. Fusco, A. Pontecorvi, L. De Marinis, and A. Giustina Prevalence of Vertebral Fractures in Men with Acromegaly J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4649 - 4655. [Abstract] [Full Text] [PDF]

				M. Bidlingmaier Problems with GH assays and strategies toward standardization Eur. J. Endocrinol., December 1, 2008; 159(suppl_1): S41 - S44. [Abstract] [Full Text] [PDF]

				C. E. Higham and P. J. Trainer Growth hormone excess and the development of growth hormone receptor antagonists Exp Physiol, November 1, 2008; 93(11): 1157 - 1169. [Abstract] [Full Text] [PDF]

				M. Losa, L. Gioia, P. Picozzi, A. Franzin, M. Valle, M. Giovanelli, and P. Mortini The Role of Stereotactic Radiotherapy in Patients with Growth Hormone-Secreting Pituitary Adenoma J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2546 - 2552. [Abstract] [Full Text] [PDF]

				H. Gouya, O. Vignaux, P. Le Roux, P. Chanson, J. Bertherat, X. Bertagna, and P. Legmann Rapidly Reversible Myocardial Edema in Patients with Acromegaly: Assessment with Ultrafast T2 Mapping in a Single-Breath-Hold MRI Sequence Am. J. Roentgenol., June 1, 2008; 190(6): 1576 - 1582. [Abstract] [Full Text] [PDF]

				A. Colao and G. Lombardi Should We Still Use Glucose-Suppressed Growth Hormone Levels for the Evaluation of Acromegaly? J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1181 - 1182. [Full Text] [PDF]

				A. M. Arafat, M. Mohlig, M. O. Weickert, F. H. Perschel, J. Purschwitz, J. Spranger, C. J. Strasburger, C. Schofl, and A. F. H. Pfeiffer Growth Hormone Response during Oral Glucose Tolerance Test: The Impact of Assay Method on the Estimation of Reference Values in Patients with Acromegaly and in Healthy Controls, and the Role of Gender, Age, and Body Mass Index J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1254 - 1262. [Abstract] [Full Text] [PDF]

				E. Resmini, P. Dadati, J.-L. Ravetti, G. Zona, R. Spaziante, A. Saveanu, P. Jaquet, M. D. Culler, F. Bianchi, A. Rebora, et al. Rapid Pituitary Tumor Shrinkage with Dissociation between Antiproliferative and Antisecretory Effects of a Long-Acting Octreotide in an Acromegalic Patient J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1592 - 1599. [Abstract] [Full Text] [PDF]

				P. Maison, A.-I. Tropeano, I. Macquin-Mavier, A. Giustina, and P. Chanson Impact of Somatostatin Analogs on the Heart in Acromegaly: A Metaanalysis J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1743 - 1747. [Abstract] [Full Text] [PDF]

				I Schreiber, M Buchfelder, M Droste, K Forssmann, K Mann, B Saller, and C J Strasburger Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study Eur. J. Endocrinol., January 1, 2007; 156(1): 75 - 82. [Abstract] [Full Text] [PDF]